Skip to content

Weave Communications

US · WEAV #3634 by market cap Listed 2021
7.37 -0.01 -0.14%
Live - 5344 symbols - heartbeat 108s ago · 2026-10-08 07:58
Pre-market 7.37 0.00%
After-hours 7.37 0.00%
Market cap
592.92M
P/B
6.98
EPS
-0.37
Reader sentiment Are you bullish or bearish on WEAV?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 6.98 In line with history 54th percentile
5-year average 6.77 · #35 of 41 in Health Information Services
P/E ratio -27.30 Cheap vs history 11th percentile
5-year average -17.27 · forward -34.27
P/S ratio 2.30 Cheap vs history 25th percentile
5-year average 3.58 · forward 2.03 · #22 of 42 in Health Information Services

Vs. peers Health Information Services

Company Market cap P/E (TTM) P/B Div yield
Weave Communications (WEAV) 592.92M -27.30 6.98 0.00%
Veeva Systems (VEEV) 45.74B 46.31 6.15 0.00%
Tempus AI (TEM) 12.69B -48.85 28.53 0.00%
BrightSpring Health Services (BTSG) 12.62B 38.67 6.16 0.00%
Hinge Health (HNGE) 7.90B 73.14 22.93 0.00%
HealthEquity (HQY) 7.60B 33.18 3.82 0.00%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value8.09 Economic moatNone UncertaintyVery High

Trading 9.7% below Morningstar's fair value estimate.

Fair value

Weave Communications Inc earns a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 9% discount to our quantitative fair value estimate of $8.09 per share; however, caution is warranted due to this estimate's very high uncertainty rating.

The firm's balance sheet increases our valuation estimate. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. For example, the firm's EBITDA/interest coverage ratio of -1.6 falls in the bottom 20% compared with peers globally. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. We believe this is a sign that shares could be cheap.

Alternatively, the company's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to EBITDA ratio of 39.6, a core component of valuation, falls in the top 20% compared with global peers. This suggests that the value of its enterprise value, or the value of its shares and debt, is a high multiple of the generated EBITDA. Despite our favorable price/fair value ratio, this characteristic is a negative attribute.

Economic moat

With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 07:58:32 · For reference only, not investment advice and not tailored to your situation.